ReShape Lifesciences Announces Fourth Quarter and Full Year 2020 Financial Results
SAN CLEMENTE, CA / ACCESSWIRE / March 10, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS), a global weight-loss solutions leader, today...
News
First-in-Class Biologic Eye Drop Regener-Eyes Announces New Clinical Advisory Board Member Dr. Sandra Cremers
PALM HARBOR, FL / ACCESSWIRE / March 10, 2021 / Regener-Eyes®, a leading first-in-class biologic eye drop made of naturally-occurring cytokines...
ClareMedica Health Partners CEO, Roberto L. Palenzuela, Invited to Participate as a Panelist for the McDermott Will & Emery LLP 2021 HPE Miami Conference
Panelists to Discuss Multiple Aspects of Risk and Value Based Provider Models MIAMI, FL / ACCESSWIRE / March 10, 2021...
Kadmon Announces U.S. FDA Has Extended the Review Period for Belumosudil in Chronic Graft-Versus-Host Disease
NEW YORK, NY / ACCESSWIRE / March 10, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced that the U.S. Food and...
Real-time Bioprocess Raman Analyzer Adoption Growing: Future Market Insights Study
Participants in the real-time bioprocess Raman analyzer market are taking efforts to minimize variable expenditure for cost-effective spectroscopy quality checks...
Virpax to Initiate Investigational New Drug (IND) Enabling Studies for Epoladerm(TM)
BERWYN, PA / ACCESSWIRE / March 10, 2021 / Virpax® Pharmaceuticals Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), today announced that...
Autoimmune Disease Treatment Opportunities Provide Impetus to Pegfilgrastim Biosimilar Market: Fact.MR Study
Manufacturers in the pegfilgrastim biosimilar market are pushing for high-potential areas of HIV and cancer to provide affordable alternatives to...
Megola Expands its Premium Hemp Extract Product Line
Superior CBD at Affordable Prices LAS VEGAS, NV / ACCESSWIRE / March 10, 2021 / Megola, Inc. (OTC:MGON) (the "Company"),...
Discovering And Investing In Neuromorphic Computing: Dr. Abdalla Kablan Is Creating A New Path For Better Artificial Intelligence From The Heart Of Arabia
NEW YORK, NY / ACCESSWIRE / March 10, 2021 / The future is full of exciting new technologies. Some of...
Elsevier and LexisNexis Collaborate to Increase Access to Patent Information in Pharma and Chemical R&D Workflows
Reaxys and LexisNexis Intellectual Property teams join forces to advance strategic insights across IP, patent data and analytics for chemistry...
9 Meters Biopharma, Inc. to Participate in the following Virtual March Investor Conferences
- Oppenheimer 31st Annual Healthcare Conference - March 16th - 18th - Maxim Group 2021 Emerging Growth Virtual Conference -...
XPhyto Partner Receives ISO Certification for 25-Minute COVID-19 RT-PCR Test
VANCOUVER, BC / ACCESSWIRE / March 10, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY / OTCQB:XPHYF / FSE:4XT) ("XPhyto" or the...
Pure Extracts Technologies Corp. Announces Listing of Warrants on the Canadian Securities Exchange Under the Symbol PULL.WT Commencing March 10, 2021
Not for distribution to United States newswire services or for release, publication, distribution ordissemination, directly or indirectly, in whole or...
Bavarian Nordic A/S Announces Completion of Directed Issue and Private Placement of 5,150,000 New Ordinary Shares
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH...
Aquestive Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Libervant™ (diazepam) Buccal Film New Drug Application (NDA) resubmission expected end of second quarter 2021Epinephrine program and development strategy to...
R1 RCM to Present at the KeyBanc Life Sciences & MedTech Investor Forum
CHICAGO, March 09, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform...
BioSig CEO Kenneth L. Londoner to Present at the 33rd Annual Virtual ROTH Conference
Westport, CT, March 09, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology...
Sugarbud Announces $4.0 Million Bought-Deal Public Offering of Units
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, March 09, 2021 (GLOBE NEWSWIRE)...
Checkpoint Therapeutics Reports Full-Year 2020 Financial Results and Recent Corporate Highlights
NEW YORK, March 09, 2021 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology...
Viridian Therapeutics To Host Conference Call Discussing Fourth Quarter And Full Year 2020 Results And Corporate Update
BOULDER, Colo., March 09, 2021 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company advancing new treatments for...